Clik here to view.
Bristol-Myers Squibb to Present at Bank of America Merrill Lynch Global...
Wednesday, September 7th 2016 at 2:41pm UTC NEW YORK–(BUSINESS WIRE)– Bristol-Myers Squibb Company (NYSE:BMY) will present at the Bank of America Merrill Lynch Global Health Care Conference on...
View ArticleClik here to view.
Kadmon Reports Financial and Operational Results for the Three and Six Months...
Wednesday, September 7th 2016 at 8:01pm UTC NEW YORK–(BUSINESS WIRE)– Kadmon Holdings, Inc. (NYSE:KDMN), a fully integrated biopharmaceutical company engaged in the discovery, development and...
View ArticleClik here to view.
Americord Expands Manhattan Offices
Wednesday, September 7th 2016 at 7:53pm UTC NEW YORK–(BUSINESS WIRE)– Americord, the fastest growing cord blood bank in the country, and a leader in the advancement of umbilical cord blood, cord...
View ArticleClik here to view.
Intec Pharma to Participate in Upcoming September Conferences
Wednesday, September 7th 2016 at 7:21pm UTC JERUSALEM–(BUSINESS WIRE)– Intec Pharma Ltd. (Nasdaq:NTEC), a late stage biopharmaceutical company focused on developing drugs based on its proprietary...
View ArticleClik here to view.
Medidata to Present at Deutsche Bank 2016 Technology Conference
Wednesday, September 7th 2016 at 9:30pm UTC NEW YORK–(BUSINESS WIRE)– Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today...
View ArticleClik here to view.
Ovid Therapeutics Receives Orphan Drug Designation from the U.S. FDA for...
Thursday, September 8th 2016 at 12:00pm UTC NEW YORK–(BUSINESS WIRE)– Ovid Therapeutics, a privately held biopharmaceutical company based in New York City, announced today that the U.S. Food and Drug...
View ArticleClik here to view.
Cellectis Reports 2nd Quarter and First Half Year 2016 Financial Results
Thursday, September 8th 2016 at 9:30pm UTC – First patient dosed in phase 1 clinical trial for UCART19 – UCART 123 manufacturing ongoing – Strong cash position of $300 million1 (€270 million) as of...
View ArticleClik here to view.
Teleflex to Present at the 2016 Morgan Stanley Global Healthcare Conference
Thursday, September 8th 2016 at 10:45am UTC WAYNE, Pa.–(BUSINESS WIRE)– Benson Smith, Chairman and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 2016 Morgan Stanley Global...
View ArticleClik here to view.
Provectus Biopharmaceuticals to Present at Rodman & Renshaw’s 18th Annual...
Thursday, September 8th 2016 at 10:00am UTC Presentation Scheduled for 3 PM Eastern, Tuesday, September 13, 2016 Conference at Lotte New York Palace Hotel, September 11-13, 2016 KNOXVILLE,...
View ArticleClik here to view.
vTv Therapeutics to Present at the Rodman & Renshaw Global Investment Conference
Thursday, September 8th 2016 at 11:00am UTC HIGH POINT, N.C.–(BUSINESS WIRE)– vTv Therapeutics Inc. (Nasdaq:VTVT), a clinical-stage biopharmaceutical company engaged in the discovery and development...
View ArticleClik here to view.
Vertex to Present at Upcoming Investor Conferences
Friday, September 9th 2016 at 7:30pm UTC BOSTON–(BUSINESS WIRE)– Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that management will present at The Morgan Stanley Global Healthcare...
View ArticleClik here to view.
NantKwest Announces Presentations at Upcoming Investment Conferences
Sunday, September 11th 2016 at 2:36am UTC CULVER CITY, Calif.–(BUSINESS WIRE)– NantKwest, Inc (NASDAQ:NK), a pioneering, next generation, clinical-stage immunotherapy company focused on harnessing the...
View ArticleClik here to view.
AmpliPhi Biosciences to Participate in Upcoming Conferences
Monday, September 12th 2016 at 8:15pm UTC SAN DIEGO–(BUSINESS WIRE)– AmpliPhi Biosciences Corporation (NYSEMKT: APHB), a global leader in the development of bacteriophage-based antibacterial therapies...
View ArticleClik here to view.
La Commission européenne accorde l’autorisation de mise sur le marché pour...
Wednesday, September 14th 2016 at 5:00am UTC Cabometyx™ (cabozantinib) est le premier et unique traitement ciblé à avoir amélioré la survie globale (OS), le taux de réponse objectif (ORR) et la survie...
View ArticleClik here to view.
University of North Carolina Wilmington Partners with Medidata to Bring...
Wednesday, September 14th 2016 at 12:30pm UTC NEW YORK & WILMINGTON, N.C.–(BUSINESS WIRE)– Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in...
View ArticleClik here to view.
European Commission Approves Ipsen’s Cabometyx™ (Cabozantinib) Tablets for...
Wednesday, September 14th 2016 at 5:00am UTC Cabometyx™ (cabozantinib) is the first and only targeted therapy to improve Overall Survival (OS), Objective Response Rate (ORR), and Progression Free...
View ArticleClik here to view.
WAVE Life Sciences to Present at the Leerink Partners Rare Disease &...
Wednesday, September 14th 2016 at 11:30am UTC CAMBRIDGE, Mass–(BUSINESS WIRE)– WAVE Life Sciences Ltd. (NASDAQ: WVE), a genetic medicines company focused on developing targeted therapies for patients...
View ArticleClik here to view.
Novocure’s Executive Chairman William Doyle to Present on Tumor Treating...
Thursday, September 15th 2016 at 11:30am UTC The NYAS’ 13th Key Symposium 2016: Bioelectronic Medicine – Technology Targeting Molecular Mechanisms brings together thought leaders to advance this...
View ArticleClik here to view.
Nativis to Present at the Ladenburg Thalmann 2016 Healthcare Conference
Thursday, September 15th 2016 at 3:59pm UTC SEATTLE–(BUSINESS WIRE)– Nativis, Inc., a clinical stage life science bio-electronics company developing non-invasive, safe and highly effective treatments...
View ArticleClik here to view.
Acorda Launches “The Many Faces of OFF” Facebook Page to Support Parkinson’s...
Thursday, September 15th 2016 at 11:00am UTC Company Hosting Educational Program on OFF Periods and Presenting Data at Upcoming 4th World Parkinson Congress (WPC) ARDSLEY, N.Y.–(BUSINESS WIRE)– Acorda...
View Article